Chlormadinone acetate versus micronized progesterone in the sequential combined hormone replacement therapy of the menopause.
- C. Pélissier, M. Maroni, H. Yaneva, S. Brin, F. Peltier-Pujol, M. Jondet
- Medicine, BiologyMaturitas
- 31 October 2001
Comparative endometrial histology in postmenopausal women with sequential hormone replacement therapy of estradiol and, either chlormadinone acetate or micronized progesterone.
- M. Jondet, M. Maroni, H. Yaneva, S. Brin, F. Peltier-Pujol, C. Pélissier
- Medicine, BiologyMaturitas
- 26 February 2002
[Venous disease in France: an unrecognized public health problem].
- A. Lafuma, F. Fagnani, F. Peltier-Pujol, A. Rauss
- MedicineJournal des Maladies Vasculaires
- 1994
The analysis of available informations suggests that chronic venous insufficiency represents approximatively 2.6% of the whole health expenditures in France, that is to say an amount of 14.7 billion of Francs for the year 1991.
In‐vitro and Ex‐vivo Inhibition of Blood Platelet Aggregation by Naftazone
- P. Durand, C. Bloy, F. Peltier-Pujol, D. Blache
- Medicine, BiologyThe Journal of pharmacy and pharmacology
- 1 June 1996
The effect of naftazone (Etioven), an original vasculotropic drug on platelet aggregation is studied.
Weak D phenotypes and transfusion safety: where do we stand in daily practice?
- F. Noizat‐Pirenne, M. Verdier, H. Ansart‐Pirenne
- MedicineTransfusion
- 1 September 2007
The serologic typing practice of weak D in a Caucasian patient population was analyzed and a transfusion strategy is proposed.
Effect of naftazone on in vivo platelet function in the rat.
- L. Mcgregor, E. Chignier, C. Bloy, C. Rousselle, F. Peltier-Pujol, J. Mcgregor
- Biology, MedicinePlatelets
- 1999
Results show that naftazone has similar inhibitory effects on rat platelet functions as ticloplidine, and could be a useful agent to modulate platelet function in patients with cardiovascular disease.